A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer
A. Nounu, A. Greenhough, K. J. Heesom, R. C. Richmond, J. Zheng, S. J. Weinstein, D. Albanes, J. A. Baron, J. L. Hopper, J. C. Figueiredo, P. A. Newcomb, N. M. Lindor, G. Casey, E. A. Platz, L. Le Marchand, , G. Rennert
This study combines proteomics and Mendelian randomization to identify aspirin-targeted proteins associated with reduced colorectal cancer risk.
bioRxiv · Aug 14, 2020Cancer Biology